Skin diseases associated with hepatitis C virus: Facts and controversies

Clinics in Dermatology

Volumn 28, Issue 5, 2010, Pages 489-496

  Rebora, Alfredo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; HEPATITIS B VACCINE; INTERFERON; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ALOPECIA; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG RESPONSE; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; GRANULOMA ANNULARE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INJECTION SITE ABSCESS; INJECTION SITE ERYTHEMA; INJECTION SITE NECROSIS; INJECTION SITE REACTION; INJECTION SITE ULCER; LICHEN PLANUS; MACULOPAPULAR RASH; MONOTHERAPY; PHOTOSENSITIVITY; POLYARTERITIS NODOSA; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; PRURIGO; PRURITUS; PSORIASIS; SIALOADENITIS; SJOEGREN SYNDROME; SKIN CANCER; SKIN DEFECT; SKIN DISEASE; UNSPECIFIED SIDE EFFECT; URTICARIA; VACCINATION; VESICULAR RASH;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; CRYOGLOBULINEMIA; FEMALE; HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; LICHEN PLANUS; MALE; PORPHYRIA CUTANEA TARDA; PREVALENCE; RIBAVIRIN; SJOGREN'S SYNDROME; SKIN DISEASES, VIRAL; SKIN NEOPLASMS; VASCULITIS;

EID: 77955936557     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.03.004     Document Type: Article

References (90)

1. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20:1-16.
2. Cacoub P., Renou C., Rosenthal E., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Médécine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000, 79:47-56.
3. Hermida M., Ferreiro M.C., Barral S., et al. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. J Virol Methods 2002, 101:29-35.
4. Jorgensen C., Legouffe M.C., Perney P., et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996, 39:1166-1171.
5. Feucht H.H., Polywka S., Zollner B., Laufs R. Greater amount of HCV-RNA in tears compared to blood. Microbiol Immunol 1994, 38:157-158.
6. Torriani F.J., Rodriguez-Torres M., Rockstroh J.K., et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004, 351:438-450.
7. Dickson R.C. Clinical manifestations of hepatitis C. Clin Liver Dis 1997, 1:569-585.
8. Houghton M., Weiner A., Han J., et al. Molecular biology of the hepatitis C virus: Implications for the diagnosis, development and control of viral disease. Hepatology 1991, 14:381.
9. Sansonno D., Cornacchiulo V., Iacobelli A.R., et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995, 21:305-312.
10. Agnello A., Chung R.T., Lee M.K. A role for hepatitis C infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490-1495.
11. Schirren C.A., Zachoval R., Schirren C.G.A. role for chronic hepatitis C infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease: Effective therapy with interferon-a. Dig Dis Sci 1995, 40:1221-1225.
12. Saadoun D., Delluc A., Piette J.C., Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Curr Opin Rheumatol 2008, 20:23-28.
13. Toll A., Celis R., Ozalla M.D., et al. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection. J Eur Acad Dermatol Venereol 2006, 20:1201-1216.
14. Rebora A. Lichen planus and the liver. Lancet 1981, 8250:805-806.
15. Mouly F., Pawlotsky J.M., Schaeffer A., et al. Association of porphyria cutanea tarda and lichen planus in a patient with chronic hepatitis C virus infection. Br J Dermatol 1995, 132:158-159.
16. Rebora A., Rongioletti F., Drago F. Parodi. Lichen planus as a side effect of HBV vaccination. Dermatology 1999, 198:1-2.
17. Carrozzo M., Gandolfo S., Carbone M., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996, 25:527-533.
18. del Olmo J.A., Pascual I., Bagan J.V., et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Eur J Oral Sci 2000, 108:378-382.
19. Gandolfo S., Carbone M., Carrozzo M., Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994, 23:119-122.
20. Mignogna M.D., Lo Muzio L., Lo Russo L., et al. Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol 2000, 39:134-139.
21. Divano M.C., Parodi A., Rebora A. Lichen planus, liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies. Dermatology 1992, 185:132-133.
22. Rebora A. Hepatitis viruses and lichen planus. Arch Dermatol 1994, 130:1328-1329.
23. Bellman B., Reddy R.K., Falanga V. Lichen planus associated with hepatitis C. Lancet 1995, 8984:1234. [letter].
24. Gimenez-Arnau A., Alayon-Lopez C., Camarasa J.G. Lichen planus and hepatitis C. J Eur Acad Dermatol Venereol 1995, 5:S84-85. [abstract].
25. Nagao Y., Sata M., Tanikawa K., et al. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest 1995, 25:910-914.
26. Schmitt E.C., Mozzanica N., Finzi A.F., et al. Hepatitis C viremia in erosive and classic lichen planus. J Eur Acad Dermatol Venereol 1995, 5:S84. [abstract].
27. Tanei R., Watanabe K., Nishiyama S. Clinical and histopathological analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol 1995, 22:316-323.
28. Sanchez-Perez J., De Castro M., Buezo G.F., et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996, 134:715-719.
29. Serpico R., Busciolano M., Femiano F. A statistical epidemiological study of a possible correlation between serum transaminase levels and viral hepatic pathology markers and lichen planus orale. Minerva Stomatol 1997, 46:97-102.
30. Bagan J.V., Ramon C., Gonzales L., et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Radiol Endod 1998, 85:532-536.
31. Mignogna M.D., Lo Muzio L., Favia G., et al. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998, 37:575-578.
32. Chuang T.Y., Stitle L., Brashear R., Lewis C. Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol 1999, 41:787-789.
33. Rossi L., Colasanto S. Clinical considerations and statistical analysis on 100 patients with oral lichen planus. Minerva Stomatol 2000, 49:393-398.
34. Beaird L.M., Kahloon N., Franco J., Fairley J.A. Incidence of hepatitis C in lichen planus. J Am Acad Dermatol 2001, 44:311-312.
35. Chainani-Wu N., Silverman S., Lozada-Nur F., et al. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 2001, 132:901-909.
36. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002, 46:207-214.
37. Figueiredo L.C., Carrilho F.J., de Andrade H.F., Migliari D.A. Oral lichen planus and hepatitis C virus infection. Oral Dis 2002, 8:42-46.
38. Cribier B., Garnier C., Laustriat D., Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994, 31:1070-1072.
39. Dupin N., Chosidow O., Lunel F., et al. Oral lichen planus and hepatitis C virus infection: a fortuitous association?. Arch Dermatol 1997, 133:1052-1053.
40. Dupond A.S., Lacour J.P., Lafont C., Ortonne J.P. Prevalence of hepatitis C virus in oral erosive lichen. Ann Dermatol Venereol 1998, 125:676-678.
41. Imhof M., Popal H., Lee J.H., et al. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Dermatology 1997, 195:1-5.
42. Grote M., Reichart P.A., Berg T., et al. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 1998, 29:1034-1035.
43. Ilter N., Senol E., Gurer M.A., Altay O. Lichen planus and hepatitis C-virus infection in Turkish patients. J Eur Acad Dermatol Venereol 1998, 10:192-193.
44. Kirtak N., Inaloz H.S. Ozgoztasi, Erbagci Z. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol 2000, 16:1159-1161.
45. Erkek E., Bozdogan Ö., Olut A.I. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 2001, 26:540-544.
46. Ingafou M., Porter S.R., Scully C., Teo C.G. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 1998, 27:65-66.
47. Tucker S.C., Coulson I.C.H. Lichen planus is not associated with hepatitis C virus infection in patients from north west England. Acta Derm Venereol 1999, 79:378-379.
48. Roy K., Bagg J. Hepatitis C virus and oral disease: a critical review. Oral Dis 1999, 5:270-277.
49. van der Meij E.H., van der Waal I. Hepatitis C virus infection and oral lichen planus: a report from The Netherlands. J Oral Pathol Med 2000, 29:255-258.
50. Ibrahim H.A., Baddour M.M., Morsi M.G., Abdelkader A.A. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?. East Mediterr Health J 1999, 5:71-78.
51. Mignogna M.D., Fedele S., Lo Russo L., et al. Unexpected low incidence of oral lichen planus in an HCV hyperendemic area of Southern Italy. Gastroenterology 2001, 121:1528-1529.
52. Pawlotsky J.M., Benchiki H., Pellet C., et al. Lichen planus and HCV genotypes. Br J Dermatol 1995, 133:666-667.
53. Lodi G., Carrozzo M., Hallett R., et al. HCV-genotypes in Italian patients with HCV related oral lichen planus. J Oral Pathol Med 1997, 26:381-384.
54. Nagao Y., Sata M., Itoh K., et al. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996, 26:495-498.
55. La Nasa G., Cottoni F., Mulargia M., et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995, 132:897-900.
56. Carrozzo M., Francia di Celle P., Gandolfo S., et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus associated oral lichen planus. Br J Dermatol 2001, 144:803-808.
57. Boyd A.S., Nanney L.B., King L.E. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol 1998, 37:260-262.
58. Arrieta J.J., Rodriguez-Inigo E., Casqueiro M., et al. Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology 2000, 32:97-103.
59. Nagao Y., Sata M., Noguchi S., et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 2000, 29:259-266.
60. Carrozzo M., Quadri R., Latorre P., et al. Molecular evidence that hepatitis C virus replicates in the oral mucosa. J Hepatol 2002, 37:364-369.
61. Pilli M, Vescovi P, Manfredi M, et al. Oral lichen planus infiltrating T cells: a pathogenetic role for HCV-specific T cell responses?. Proceedings of the 8th International Symposium on Hepatitis C Virus and Related Viruses, Paris, September 2-5 2001, 34. [abstract].
62. Harden D., Skelton H., Smith K.J. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus. J Am Acad Dermatol 2003, 49:847-852.
63. Lodi G., Olsen I., Piattelli A., et al. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. J Oral Pathol Med 1997, 26:36-39.
64. Nagao Y., Sata M., Abe K., et al. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 1997, 32:324-329.
65. Fleischmann M., Celerier P., Bernard P., et al. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology 1996, 192:50-55.
66. Carrozzo M., Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003, 14:115-127.
67. Parodi A., Cozzani E., Massone C., et al. Prevalence of stratified epithelium-specific antinuclear antibodies in 138 patients with lichen planus. J Am Acad Dermatol 2007, 56:974-978.
68. Carson C.W., Conn D.L., Czaja A.J., et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304-309.
69. Hortelano Martínez E., Calvo Catalá J., Gonzalez-Cruz Cervellera M.I., et al. Polyarteritis nodosa associated with hepatitis C virus. An Med Interna 1997, 14:241-243. [Abstract].
70. Pawlotsky J.M., Ben Yahia M., Andre C., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841-848.
71. Loustaud-Ratti V., Riche A., Liozon E., et al. Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2001, 28:2245-2251.
72. Ramos-Casals M., Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 2005, 17:447-455.
73. Pirisi M., Scott C., Fabris C., et al. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 1994, 29:940-942.
74. Scott C.A., Avellini C., Desinan L., et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology 1997, 30:41-48.
75. Yamamoto T., Katayama I., Nishioka K. Psoriasis and hepatitis C virus. Acta Derm Venereol 1995, 75:482-483.
76. Chouela E., Abeldano A., Panetta J., et al. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 1996, 35:797-799.
77. Burrows N.P., Norris P.G., Alexander G., Wreghitt T. Chronic hepatitis C infection and psoriasis. Dermatology 1995, 190:173. [letter].
78. Citro V., Fristachi R., Tarantino G. Extensive psoriasis induced by pegylated interferon: a case report. J Med Case Rep 2007, 1:86.
79. Soylu S., Gül U., Kiliç A. Cutaneous manifestations in patients positive for anti-hepatitis C virus antibodies. Acta Derm Venereol 2007, 87:49-53.
80. Kanazawa K., Yaoita H., Tsuda F., et al. Association of prurigo with hepatitis C virus infection. Arch Dermatol 1995, 131:852-853.
81. Nagao Y., Sata M., Tanikawa K., et al. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 1995, 24:354-360.
82. Nagao Y., Sata M., Fukuizumi K., et al. Oral cancer and hepatitis C virus (HCV): can HCV alone cause oral cancer?-a case report. Kurume Med J 1996, 43:97-100.
83. Nagao Y., Sata M., Noguchi S., et al. Various extrahepatic manifestations caused by hepatitis C virus infection. Int J Mol Med 1999, 4:621-625.
84. Carrozzo M., Carbone M., Gandolfo S., et al. An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol 1997, 33:220-225.
85. Porter S.R., Lodi G., Chandler K., Kumar N. Development of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Oral Oncol 1997, 33:58-59.
86. Cervoni E. Hepatitis C. Lancet 1998, 9099:1209-1210.
87. Lo Muzio L., Mignogna M.D., Favia G., et al. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 1998, 34:239-246.
88. Nagao Y., Sata M., Fukuizumi K., et al. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res 1997, 8:173-177.
89. Fujimoto T., Tomimatsu M., Iga D., et al. Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C. J Gastroenterol Hepatol 2008, 23:e432-e437.
90. Descamps V. Manifestations cutanées au cours des traitements par interféron. Presse Med 2005, 34:1668-1672.